Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ozurdex in vitrectomized DME (CHAMPLAIN)
NCT00799227Phase 2Completed
- Sponsor
- Allergan
- Start
- Jan 2009
- Primary completion
- Dec 2009
- Modality
- Orthosteric Ligands
- Countries
- 2
01
Overview
A Phase 2 trial of dexamethasone in diabetic macular edema (DME), sponsored by Allergan. Started Jan 2009; status: completed.
02
Drugs
dexamethasone
03
Conditions
diabetic macular edema (DME)
Beyond the preview
Go deeper on NCT00799227.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00799227.